MiNK Therapeutics (NASDAQ:INKT – Get Free Report) and SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation. Valuation & Earnings This table compares MiNK Therapeutics […]
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) – Analysts at Wedbush raised their Q1 2024 EPS estimates for SpringWorks Therapeutics in a research report issued to clients and investors on Tuesday, February 27th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings of ($1.27) per share for the quarter, up from their […]
Takeda welcomes new leader—Chutes & Ladders fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Through serendipity, science, and rigor, SpringWorks Therapeutics, a targeted oncology company, marks success with the first FDA-approved treatment for Desmoid Tumor.
Serendipity and science: Building a multibillion-dollar breakthrough in oncology independantexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from independantexpress.com Daily Mail and Mail on Sunday newspapers.